Celeste, Maria Grazia, Francesca De Marco, Claudio Fresco, Giuseppe Musumeci, and Roberto Ravasio. “Budget Impact Analysis of Dabigatran Compared With Rivaroxaban in the Prevention of the Thromboembolic Risk in Patients With Non-Valvular Atrial Fibrillation”. Farmeconomia. Health economics and therapeutic pathways 18, no. 1 (November 14, 2017). Accessed July 23, 2025. https://provafe.seedstm.com/index.php/FE/article/view/1327.